These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2266390)

  • 1. SPECT quantitation of iodine-131 concentration in phantoms and human tumors.
    Israel O; Iosilevsky G; Front D; Bettman L; Frenkel A; Ish-Shalom S; Steiner M; Ben-Harush M; Kolodny GM
    J Nucl Med; 1990 Dec; 31(12):1945-9. PubMed ID: 2266390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
    Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and therapy of neuroectodermal tumors].
    Adolph J; Kimmig B
    Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
    Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
    Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors.
    Colombo L; Vignati A; Lomuscio G; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
    Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
    Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
    J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
    Khafagi FA; Shapiro B; Fig LM; Mallette S; Sisson JC
    J Nucl Med; 1989 Apr; 30(4):481-9. PubMed ID: 2738677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
    J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant pheochromocytoma with a new radiopharmaceutical.
    Sisson J; Shapiro B; Beierwaltes WH; Nakajo M; Glowniak J; Mangner T; Carey JE; Swanson DP; Copp J; Satterlee W
    Trans Assoc Am Physicians; 1983; 96():209-17. PubMed ID: 6679954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization procedures in pheochromocytoma and neuroblastoma.
    Fischer M; Galanski M; Winterberg B; Vetter H
    Cardiology; 1985; 72 Suppl 1():143-6. PubMed ID: 3902227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioisotope therapy of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine--absorbed dose assessments using SPECT].
    Aritake S
    Kaku Igaku; 1992 Jun; 29(6):667-78. PubMed ID: 1640651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours.
    Monsieurs MA; Thierens HM; Vral A; Brans B; De Ridder L; Dierckx RA
    Nucl Med Commun; 2001 Apr; 22(4):367-74. PubMed ID: 11338046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.
    Moyes JS; Babich JW; Carter R; Meller ST; Agrawal M; McElwain TJ
    J Nucl Med; 1989 Apr; 30(4):474-80. PubMed ID: 2738676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance.
    Wafelman AR; Nortier YL; Rosing H; Maessen HJ; Taal BG; Hoefnagel CA; Maes RA; Beijnen JH
    Nucl Med Commun; 1995 Sep; 16(9):767-72. PubMed ID: 7478409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radionuclide therapy of Sipple syndrome using iodine-131 metaiodobenzylguanidine].
    Furusawa M; Shimomura O; Tomiguchi S; Hirota Y; Takahashi M; Yamauchi J; Iwaoka D; Satoh T
    Kaku Igaku; 1992 Sep; 29(9):1133-8. PubMed ID: 1360550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Horizons in radionuclide therapy: 1985 update.
    Beierwaltes WH
    J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.